Bacopa monnieri for women: are there any special considerations?

Bacopa monnieri is one of the most researched herbs for memory, yet almost all of the trials were carried out in mixed groups. Our editorial team looked at what the evidence shows and where women genuinely need to think differently – from the thyroid to pregnancy.
What Bacopa monnieri is and why women ask about it
Bacopa monnieri, known in Ayurvedic medicine as brahmi, is a creeping wetland herb that has been used in India for centuries as a so-called "medhya rasayana" – a tonic for memory and the mind. In the UK it is sold as a food supplement, usually as a standardised extract containing a stated percentage of bacosides, the saponin compounds thought to be responsible for most of its activity.
Interest from women has grown for understandable reasons. Bacopa is marketed for focus, stress resilience and memory, and those are exactly the areas where many women notice changes – during demanding training blocks, around the menstrual cycle, after pregnancy or in perimenopause. The obvious question is whether a herb studied mostly in mixed groups behaves any differently in a female body.
The honest starting point is that very few trials were designed to answer that question directly. Most randomised studies recruited both sexes, and few reported results separately for women. What we can do is look at the general evidence, then consider the specific situations – hormones, pregnancy, thyroid function, medication – where female physiology makes a practical difference.
It is also worth stressing that Bacopa is not a stimulant. Unlike caffeine, it does not produce an immediate lift. In trials, effects on memory tasks typically appeared only after eight to twelve weeks of daily use, which shapes how it should be judged.
What the research shows overall
The best-known trials are relatively small but consistent. Stough and colleagues reported in 2001 that twelve weeks of a standardised extract improved speed of visual information processing and memory consolidation in healthy adults. Calabrese and co-workers found improvements in delayed recall and reductions in some anxiety scores in older volunteers over a similar period.
A 2014 meta-analysis by Kongkeaw and colleagues pooled the controlled trials and concluded that Bacopa may improve attention-related measures such as choice reaction time, while noting that the studies were short and heterogeneous. An earlier systematic review by Pase and co-workers reached a cautiously positive conclusion about memory, particularly free recall.
- Most consistent finding: modest improvement in memory acquisition and retention after 8–12 weeks.
- Less consistent: effects on anxiety, mood and general wellbeing.
- Not supported: any direct effect on strength, endurance or body composition.
For athletes, this means Bacopa belongs to the cognitive and recovery-of-the-mind category rather than performance aids. A woman hoping for sharper concentration during exam season alongside training may reasonably consider it; someone expecting faster sprint times will be disappointed.
Effect sizes are modest. Even in positive trials the difference between groups is the kind that shows up on sensitive tests rather than something most people would describe as dramatic. That realistic framing helps avoid the cycle of buying ever more supplements in search of a noticeable effect.

Are there differences for women?
There is no strong evidence that Bacopa's cognitive effects differ by sex. Sub-analyses are scarce, and the trials that included roughly equal numbers of men and women did not flag sex as a major factor. The differences that matter are more practical than pharmacological.
The first concerns gastrointestinal tolerance. The most common side effects reported in trials are nausea, stomach cramps and looser stools. Women who already experience digestive changes during the luteal phase or menstruation may notice these more, so taking the extract with food is a sensible default.
The second concerns the thyroid. Animal research, including a study by Kar and colleagues in mice, suggested that high doses of Bacopa extract increased thyroxine (T4) concentrations. Human data are lacking, but thyroid disorders are considerably more common in women than men. Anyone taking levothyroxine or being investigated for an overactive or underactive thyroid should discuss Bacopa with their GP before starting.
The third is the interplay with hormones and mood. Bacopa has not been shown to alter oestrogen or progesterone, but some women report that sedation or mild fatigue – also listed as side effects – coincides with premenstrual tiredness. Starting in the follicular phase and observing how the first full cycle feels is a pragmatic approach.
Pregnancy, breastfeeding and medication
Safety during pregnancy and breastfeeding has not been established. There are no adequate human studies, and herbal products do not undergo the reproductive toxicity testing required for medicines. The editorial position, consistent with standard pharmacy advice in the UK, is that Bacopa should be avoided while trying to conceive, during pregnancy and while breastfeeding.
Interactions deserve attention because many women use regular medication. Laboratory work suggests that Bacopa extracts can influence certain liver enzymes involved in drug metabolism, although the clinical significance is uncertain. People taking antidepressants, anti-epileptic drugs, thyroid hormones or sedatives should involve their pharmacist before combining these with a herbal extract.
| Situation | Practical position |
|---|---|
| Pregnancy or breastfeeding | Avoid – no adequate safety data |
| Thyroid disease or levothyroxine | Discuss with GP; thyroid tests may be affected |
| Antidepressants or sedatives | Pharmacist review; possible additive drowsiness |
| Combined oral contraceptive | No known interaction, but data are limited |
| Sensitive stomach, IBS | Take with meals; start with a lower amount |
Hormonal contraception has not been shown to interact with Bacopa, but the absence of evidence here simply reflects a lack of research. Women who rely on contraception should not assume any herbal product is automatically neutral.
Competing athletes should remember that supplements may be contaminated with prohibited substances. Bacopa itself is not on the World Anti-Doping Agency list, but under the strict liability principle the athlete is responsible for whatever is in the capsule. Choosing products tested under a recognised batch-testing scheme reduces that risk.
How it is typically used
In the published trials, adult participants usually took 300–450 mg per day of an extract standardised to around 50–55% bacosides, often in a single dose with food. Labels on products sold in Britain broadly follow these amounts. Because effects are slow to develop, trials ran for at least eight weeks before assessing outcomes.
A reasonable approach for a healthy adult woman, after checking the factors above, is to follow the label of a standardised product, take it with breakfast or lunch, and give it two to three months before judging whether it helps. Keeping a short weekly note on sleep, concentration and digestion makes that judgement more objective.
Raw powdered herb is not equivalent to a standardised extract. The bacoside content of unprocessed powder varies widely, and doses used in trials cannot be translated to it directly. Quality also varies between suppliers, which is why third-party testing matters.
If digestive discomfort, unusual fatigue, palpitations or mood changes appear, stopping is sensible. The herb is not habit-forming and there is no need for a gradual withdrawal.
Editorial team's conclusions
Bacopa monnieri has a modest but reasonably consistent evidence base for memory and attention after several weeks of use. There is no convincing evidence that it works differently in women, and it has no direct effect on physical performance.
The female-specific points are practical: avoid it in pregnancy and breastfeeding, take thyroid health seriously given the animal data, and be aware that gastrointestinal effects may be more noticeable at certain points in the cycle.
Used sensibly, in standardised form and with realistic expectations, Bacopa is a low-intensity option rather than a transformation. Sleep, nutrition and training load will always do more for concentration than any single herb.
For further reading, see our articles on rhodiola and stress during training, on how sleep quality affects recovery in women, and on choosing batch-tested supplements.
References
- Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl). 2001;156(4):481–484.
- Calabrese C, Gregory WL, Leo M, et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707–713.
- Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528–535.
- Pase MP, Kean J, Sarris J, et al. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med. 2012;18(7):647–652.
- Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313–326.
- Kar A, Panda S, Bharti S. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol. 2002;81(2):281–285.
- Morgan A, Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med. 2010;16(7):753–759.


